MedTrace Logo

Daxxin Psoriasis Shampoo PMCF

NCT06771648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2026-04-24

No results posted yet for this study

Summary

The goal of this clinical investigation is to verify the performance and safety of the CE-marked Daxxin Psoriasis Shampoo to treat scalp psoriasis. Forty-one subjects with moderate scalp psoriasis are planned to be recruited at one site in Sweden. Subjects will be asked to use the shampoo between 3 and 7 times a week, as per the instructions for use from the manufacturer, for a period of 6 weeks.

Conditions

  • Scalp Psoriasis

Interventions

DEVICE

Daxxin Psoriasis Shampoo

Daxxin Psoriasis Shampoo at least 3 times a week and at most once a day as per instructions for use

Sponsors & Collaborators

  • Daxxin AB

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-24
Primary Completion
2025-12-19
Completion
2025-12-19

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06771648 on ClinicalTrials.gov